Esophagogastric Junction Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Esophagogastric Junction Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab [Phase 1]
Phase 1 study of DKN-01 with paclitaxel or pembrolizumab in esophageal and gastroesophageal cancers has been completed.
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: Chemotherapy and Pembrolizumab, Followed by Pembrolizumab and Olaparib As Firstline Therapy in Her-2 Negative Gastric/GEJ Adenocarcinoma [Phase 2]
This Phase 2 trial update indicates completion of a first-line therapy approach for HER2-negative gastric/GEJ adenocarcinoma using chemother…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer [Phase 3]
Phase 3 trial update on PD-1 inhibitor in combination with chemotherapy as adjuvant treatment for gastric cancer, with the study currently a…
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence [Phase 2]
Phase 2 clinical trial comparing postoperative immunotherapy to standard chemotherapy for high-risk gastric cancer after surgery.
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: PD-1 Monoclonal Antibody Combined With FLOT Regimen for Neoadjuvant Therapy of Gastric Adenocarcinoma [Phase 2]
Phase 2 trial investigating PD-1 monoclonal antibody with FLOT chemotherapy as neoadjuvant therapy for gastric adenocarcinoma and tumors at …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-07-01Clinical Trial Update: Camrelizumab Combined With Apatinib for Advanced Gastric or Esophagogastric Adenocarcinoma [Phase 2]
Phase 2 trial update evaluating camrelizumab in combination with apatinib for advanced gastric/GEJ adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2021-04-13Clinical Trial Update: FOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III) [Phase 2]
A Phase 2 clinical trial comparing FOLFOX6 vs mFOLFIRINOX as first-line chemotherapy in metastatic gastric cancer or esophagogastric junctio…
-
CLINICAL_TRIALS trial_result · 2020-02-28Clinical Trial Update: Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol. [Phase 2]
Phase II clinical trial protocol assessing palliative short-course hypofractionated radiotherapy followed by chemotherapy for adenocarcinoma…
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: Perioperative Combination Chemotherapy Versus Chemoradiation for Locally Advanced EGJ Adenocarcinoma [Phase 3]
A Phase 3 trial comparing perioperative combination chemotherapy to chemoradiation for locally advanced Esophagogastric Junction adenocarcin…
-
CLINICAL_TRIALS trial_result · 2015-05-19Clinical Trial Update: Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction [Phase 3]
A Phase 3 trial evaluating paclitaxel plus capecitabine with capecitabine maintenance in metastatic adenocarcinoma of the stomach or esophag…
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer [Phase 1, Phase 2]
A combination of AMG 102 with ECX (epirubicin, cisplatin, capecitabine) was evaluated in Phase 1/2 for unresectable locally advanced or meta…
-
CLINICAL_TRIALS trial_result · 2010-05-14Clinical Trial Update: Efficacy of Cetuximab in Combination With Irinotecan and 5- FU/FA in Treatment of Metastatic Gastric Cancer [Phase 2]
Phase 2 study evaluating cetuximab with irinotecan and 5-FU/folinic acid in metastatic gastric cancer. The trial has completed and reported …